Welcome to our dedicated page for Northrim Bancorp SEC filings (Ticker: NRIM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Monitoring the health of Alaska’s economy often starts with Northrim Bancorp’s loan book. Investors searching for credit quality, net interest margin or mortgage origination trends frequently ask, “Where can I read the Northrim Bancorp quarterly earnings report 10-Q filing?” and “How do I track Northrim Bancorp insider trading Form 4 transactions?”
Stock Titan’s AI-powered summaries answer those questions instantly. Our engine scans every new 10-K, 10-Q, 8-K and Form 4 the moment they hit EDGAR, delivers plain-English explanations, and flags the tables that matter—capital ratios for the Community Banking segment, hedging details inside Home Mortgage Lending, and any Northrim Bancorp 8-K material events explained in context. You’ll see Northrim Bancorp Form 4 insider transactions real-time, receive alerts when directors buy shares, and get a Northrim Bancorp annual report 10-K simplified to the essentials.
Whether you need Northrim Bancorp proxy statement executive compensation data before voting, want to compare quarter-over-quarter loan-loss provisions, or prefer understanding Northrim Bancorp SEC documents with AI instead of wading through 300 pages, this page delivers. Download full filings, skim concise highlights, or explore trend charts compiled from original disclosures. It’s the fastest route to Northrim Bancorp earnings report filing analysis and executive stock transactions Form 4 monitoring—everything organized so you can act with confidence.
Disc Medicine, Inc. (IRON) filed a Form 144 indicating a proposed sale of 53,215 common shares through Merrill Lynch. At the most recent market price used in the filing, the shares are valued at $3.23 million. The filing lists total shares outstanding at 34,634,295, so the planned sale represents roughly 0.15 % of outstanding stock, a modest proportion that limits potential market impact.
The seller acquired the stock on 05 May 2020 via a private placement for cash. In the past three months related entities—Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P.—sold a combined 1,848 shares for gross proceeds of $112,964. The anticipated sale date for the new block is 23 July 2025, and the shares are expected to be sold on the Nasdaq exchange.
FAQ
What is the current stock price of Northrim Bancorp (NRIM)?
What is the market cap of Northrim Bancorp (NRIM)?
What is Northrim Bancorp Inc?
What are the primary business segments of Northrim Bancorp?
Which products and services does the company offer?
How does Northrim Bancorp emphasize customer service?
How does the company manage risk?
What sets Northrim Bancorp apart in the competitive banking sector?
Is Northrim Bancorp registered with relevant financial authorities?
